Notification
July 01 2004 - 8:32AM
UK Regulatory
RNS Number:3751A
Celltech Group PLC
01 July 2004
1 July 2004
Celltech Group plc (symbol: CLL) announces today that it has received
notification from the New York Stock Exchange (the "NYSE") that, in accordance
with its standard operating procedures, the NYSE intends to halt trading of
Celltech's American Depositary Receipts as of 10:00 a.m. (New York City time)
today as such time is the close of the offer period for the recommended cash
tender offer by UCB S.A. for the entire issued share capital of Celltech. The
offer period commenced on May 19, 2004 and was extended on June 18, 2004.
Celltech has been informed that the halt of trading shall continue until such
time as UCB makes public announcement of the level of acceptances as of the
close of the offer period and its intention whether to extend the offer period
or commence the subsequent offer period. In accordance with the provisions of
the U.K. City Code on Takeovers and Mergers and the Securities Exchange Act of
1934 and as set out in the Offer Document dated May 19, 2004, UCB intends to
make such announcement no later than 8:00 a.m. (London time) in the United
Kingdom, and by 8:00 a.m. (New York City time) in the United States, on July 2,
2004.
Enquiries:
Richard Bungay Director of Corporate Communications +44 (0)1753 534655
John Slater Company Secretary +44 (0)1753 534655
This information is provided by RNS
The company news service from the London Stock Exchange
END
MSCRBMTTMMTMBMI
Coca-cola Hbc (LSE:CCH)
Historical Stock Chart
From Sep 2024 to Oct 2024
Coca-cola Hbc (LSE:CCH)
Historical Stock Chart
From Oct 2023 to Oct 2024